Indeed, we could demonstrate for the first time the increase of Melan-A released in EVs after 48 h of treatment with MAPKi (Figure 4D), which could mirror the described tumour cell surface increased expression (Pieper et al., 2018). The gene discussed is MLANA; the disease is neoplasm.